pathology of endocrine glands - ii

47
Pathology of Endocrine Glands - II Thyroid Jaroslava Dušková Inst. Pathol. 1st Med. Fac. Charles Univ. Prague https://www1.lf1.cuni.cz/~jdusk/ Endocrine Pancreas

Upload: zinna

Post on 24-Jan-2016

51 views

Category:

Documents


0 download

DESCRIPTION

Pathology of Endocrine Glands - II. Thyroid. Endocrine Pancreas. Jaroslava Dušková Inst. Pathol. 1st Med. Fac. Charles Univ. Prague https://www1.lf1.cuni.cz/~jdusk/. Thyroid Gland History I. China (2nd mill.b.C.) description of goitre (Charvát 1935) - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Pathology of Endocrine Glands - II

Pathology of Endocrine Glands - II

Thyroid

Jaroslava Dušková Inst. Pathol. 1st Med. Fac. Charles Univ. Prague

https://www1.lf1.cuni.cz/~jdusk/

Endocrine Pancreas

Page 2: Pathology of Endocrine Glands - II

Thyroid Gland History I.

China (2nd mill.b.C.) description of goitre

(Charvát 1935)

Vitruvius (16.a.C.) goitre in the Alpine region

Warton (1656) „ Adenographia“ the term glandula thyreoidea

Luschka (1860) mechanical support of the laryngeal structures

Page 3: Pathology of Endocrine Glands - II

Thyroid Gland History II.

Basedow (1840) hyperthyreosis

Köstl (1855 - Wien): Der endemische Kretinismus als Gegenstand

der öffentlichen Fürsorge (habilit. thesis)

Gull (1873) hypothyreosis

Murray (1883) Therapy with bovine thyroid extracts

Page 4: Pathology of Endocrine Glands - II

Thyroid Gland History III

Hashimoto (1912) struma lymphomatosa

Kendall (1914): Tyroxine discovery

Aron a Loebe (1929) TSH discovery

Adams a Purves (1952) LATS discovery

Page 5: Pathology of Endocrine Glands - II

Thyroid Gland - embryology and fetal endocrinology

mouth epithelium, end of the 1st iu. month ductus thyreoglosus

lateral pharynx ultimobranchial bodies C- cells. parathyroid glands

fetal secretion starts at 12 weeks effect on GROWTH effect on DIFFERENTIATION

Page 6: Pathology of Endocrine Glands - II

Thyroid Gland - anatomy

Weight in adults 15-20g

over 60g (7g in a neonate) strumalobus dexter

isthmus et lobus pyramidalis

lobus sinister

aberant, accesory, ectopic gland (polyclonality should help to tell from ca)

Page 7: Pathology of Endocrine Glands - II

Thyroid Gland - physiology and regulations

hypothalamohypophysothyreoidal axis (TRH,TSH)

enzymes - deiodases autoregulation influenced by iodine

intake immune system

Page 8: Pathology of Endocrine Glands - II

Morphological Thyroid Investigation

Clinic

scintigraphy SONOGRAPHY CT

Pathology

(biopsy) FNAB histology

Page 9: Pathology of Endocrine Glands - II

Main Tasks in the Thyroid Cytology

reduction of the unnecessary surgery

diagnosis of subclinical inflammation

EARLY DIAGNOSIS of NEOPLASMS

Page 10: Pathology of Endocrine Glands - II

Thyroid Cytology - getting sample

needle 0.6-0.8mm min. 2 punctions

aspirationnonaspiration

cyst: evacuate and aspirate with the second punction the periphery

fluid: whole volume for cytology

Page 11: Pathology of Endocrine Glands - II

Thyroid Cytology- processing

Fixation– air dried – etanol / spray

(cytospin)

CYTOBLOCK

Staining: MGG HE polychrom all histo. imunocyto

TGB,calcitonin, parathormon

Page 12: Pathology of Endocrine Glands - II

Regressive changes of thyroid gland

dystrophy: amyloid deposits, calcification atrophy: due to the lack of TSH

stimmulation, postinflammatory

necrosis: only in hyperplastic or neoplastic goitre

Page 13: Pathology of Endocrine Glands - II

ThyreoiditisNON-SPECIFIC purulent non-specific granulomatose de Quervain lymphocytic (Hashimoto)

hypertrophic atrofic focal

invasive sclerosing Riedel

SPECIFIC tbc syfilis sarcoidosis

Page 14: Pathology of Endocrine Glands - II

Non-Specific Granulomatose Thyreoiditis de Quervain (1904)

Synonyma: „Giant cell“ „Subacute non-purulent“

Clin.features: Oedema, pain, eufunction, may be also silent

Histol. features: disperse granulomas with giant cells

Course: spontaneous healing by 2-4 weeks

Page 15: Pathology of Endocrine Glands - II

Thyreoiditis lymphoplasmocellularis Hashimoto - HT

Hashimoto, H.:Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse

(struma lymphomatosa)

Arch.f. klin. Chir. 97, 1912, 219

Page 16: Pathology of Endocrine Glands - II

Original HT Description

Macro - diff. parenchymatose goitre firm, elastic, gray-yellow

Micro - diffuselymfoplasmocellularlymph. foliculesONCOCYTES

Page 17: Pathology of Endocrine Glands - II

Etiopathogenesis of HT

Etiology: unclear - viri ?

Pathogenesis: dysregulation of T lymphocytes IL-1 expression Fas molecules on the

surface of thyreocytes (they have FasL) apoptosis

activation

Activity: CD 44 proteoglycan influencing migration and lymphocyte proliferation, and metastasizing

Page 18: Pathology of Endocrine Glands - II

Course of HT

a) progressive oncocytic transformation

loss of thyreocytes, transformation to a lymph- node-with-ca- meta image

hyperfunction folowed by

hypofunction

Page 19: Pathology of Endocrine Glands - II

Course of HT

b) regressive loss of parenchyma, fibrosis hypofunction

Page 20: Pathology of Endocrine Glands - II

Course of HT

c) neoplasia carcinoma lymphoma (mostly B - MALT)

Page 21: Pathology of Endocrine Glands - II

Thyroid Malignant Lymphomas

2% thyroid primary malignancies mostly women with HT clinically rapid growth, often hypothyreosis mostly B (MALT),

features of lymphoepithelial lesion both LG and HG diff. dg. HT clinical and cytology suspicion

dg. excision

Page 22: Pathology of Endocrine Glands - II

Chronic Sclerosing Thyreoiditis Riedel (1910) Synonyma: „Invasive Fibrotising“

„ Iron hard (eisenharte) goitre“

Clin.features: slight assym. edema fixation to surrounding structures eu- or hypofunction tracheal stenosis recurrens paresis

Histol. features: tissue destruction fibrotisation fixation to surrounding structures involment of the neck vessels

Course: Stabilisation, possible progression

Page 23: Pathology of Endocrine Glands - II

Thyreoidal Syndromes

hypothyreosis– inborn – cretinism

endemic, sporadic

– acquired – myxedema hyperthyreosis - thyreotoxicosis

Page 24: Pathology of Endocrine Glands - II

Hypothyreosis CRETINISMUS

disturbances of growth & differentiation

BRAIN

LUNG

BONE

Page 25: Pathology of Endocrine Glands - II

Acquired Hypothyreosis - MYXEDEMA

decreased metabolism – bradycardia, low blood pressure, water

retention, obstipation intolerance of cold lowered lipolysis

– weight increase

– hyperlipemia ATHEROSCLEROSIS

Page 26: Pathology of Endocrine Glands - II

Thyreoidal Syndromes

hypothyreosis– inborn – cretinism

endemic, sporadic

– acquired – myxedema hyperthyreosis - thyreotoxicosis

Page 27: Pathology of Endocrine Glands - II

Hyperthyreosis increased metabolism tachycardia, high blood pressure,

fibrilation,– hypercalciuria, diarrhoe

intolerance of warm increased lipolysis, glycogenolysis

– weight decrease– hyperglycemia, diabetes

muscle weekness, insomnia, exophtalmus, pretibial myxedema

Page 28: Pathology of Endocrine Glands - II

Processing of Thyroid Resecate

orientation division

– lobus dx.– isthmus (+lobus pyramidalis)– lobus sin.

cutting in cca 3mm thick lamellae– revision and extensive/complete blocking

of the encapsulated nodules periphery– any suspicious focus for histology

Page 29: Pathology of Endocrine Glands - II

Folicular Neoplasia (proliferating microfollicular lesion)

Histological diagnosis

– microfollicular adenoma

– follicular carcinoma

Cytological features

highly cellular smears– few colloid– microfollicular

formations– thyreocytes regular,

small or slightly enlarged

– bare nuclei– regressive changes:

mostly absent

Page 30: Pathology of Endocrine Glands - II

Oncocytic Tumours

adenoma– architecture follicular, trabecular– cellular atypiae without predictive value

for biological behaviour– more risk in case of solid architecture

EXCLUDE

ANGIOINVASION, CAPSULOINVASION

Page 31: Pathology of Endocrine Glands - II

Oncocytic Tumours

carcinoma– oncopapillary (may lack ground glass nuclei !)

– oncofollicular

must exhibit

ANGIOINVASION and/or

CAPSULOINVASION (all capsule thickness with extracapsular expansion)

Page 32: Pathology of Endocrine Glands - II

Papillary Carcinoma

Histological variants - WHO

microcarcinoma encapsulated follicular diff. sclerosing oxyphil cell

Histological variantsadditional

tall cell

columnar cell macrofollicular with desmopl.stroma hyal. trabecular ca

Page 33: Pathology of Endocrine Glands - II

Papillary CarcinomaCytological featuresgeneral

highly cellular smears few colloid waxy colloid, may be

absent

architecture phragments of papillae groups trabecular microfollicular syncytial formations squamous

metaplasia psammomata

NUCLEI

enlarged non - circular overlapping grooves pseudoinclusions

Page 34: Pathology of Endocrine Glands - II

Medullary Carcinoma

origin fom C-cells

clinical forms :

(parafollicular)

sporadic familiar

– MEN 2a

– MEN 2b

Page 35: Pathology of Endocrine Glands - II

Medullary Carcinoma familiar forms

MEN 2a medullary ca parathyr. adenoma pheochromocytoma

MEN 2b MEDULLARY CA marphanoid habitus mucous neuromas pheochromocytoma parathyr. adenoma -

Page 36: Pathology of Endocrine Glands - II

Medullary carcinomaC-cells (parafollicular)

sporadic familiar

MEN 2a MEN 2b

Page 37: Pathology of Endocrine Glands - II

Medullary carcinoma

Histological diagnosis

Calcitonin + amyloid +- argyrophilia +

Page 38: Pathology of Endocrine Glands - II

Medullary Carcinoma

Histological diagnosis

architecture may mimic any otherthyroid ca!!! (WHO)

Calcitonine + amyloid +- argyrophilia +

Page 39: Pathology of Endocrine Glands - II

Medullary Carcinoma

Cytological types

large cell

small cell

fusocellular

plasmocytoid

Page 40: Pathology of Endocrine Glands - II

highly malignant neoplasm of the old age with rapid progression origin:

non diagnosed differentiated ca hyperplastic goitre chronic inflammation without preceeding goitre

Undifferentiated Carcinoma(anaplastic)

Page 41: Pathology of Endocrine Glands - II

Undifferentiated Carcinoma

Histological variants (often combined)

fusocellular small cell (?) exclude lymphoma! giant cell (monstrous cells) squamous metaplasia composed

lmsa, rmsa,osa, chsa, hae, MFH,

classify as carcinoma!

Page 42: Pathology of Endocrine Glands - II

Other Types of PrimaryThyroid Carcinomas

epidermoid mucoepidermoid mixed follicular and mucoepidermoid

Page 43: Pathology of Endocrine Glands - II

Metastases into Thyroid

kidney lung breast other

Page 44: Pathology of Endocrine Glands - II

Islets of Langerhans (1869)

adults 100 000 -1000 000 cell types:

B - insulin

A - glucagon

D – somatostatin

PP – pancreatic polypeptide

D – vasoactive intestinal polypeptide

Page 45: Pathology of Endocrine Glands - II

Islets of Langerhans -

regressive changes

fibrosis (postinflamm.) - DM I mucoviscidosis – DM 10x frequency hyalinosis, amyloidosis

Page 46: Pathology of Endocrine Glands - II

Islets of Langerhans - progressive changes hyperplasia –diabetic embryopathy nesidioblastosis

- tumours– nesidioma ( event. in MEN I)

(insulinoma, glucagonoma, somatostatinoma,VIPoma, PP-oma, G cells -gastrinoma, EC – serotonin - carcinoid

– neuroendocrine carcinoma

Page 47: Pathology of Endocrine Glands - II

Islets of Langerhans - syndromes

hyperfunction – hypoglycemia (weekness , sweating, tremor,

coma)– Zollinger-Ellison, Werner Morrison, glucagonoma

hypofunction – insulin hyperglycemia – acute : polydipsia, ketoacidosis, coma, liver

steatosis , brain edema

– chronic: diabetes mellitus: microangiopathy, macroangiopathy, neuropathy, retinopathy,embryopathy